SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001789769-24-000034
Filing Date
2024-03-21
Accepted
2024-03-21 17:01:29
Documents
15
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20240321.htm   iXBRL 8-K 33315
2 EX-99.1 a2023earningspressrelease.htm EX-99.1 83956
6 LOGO imagea.jpg GRAPHIC 3565
  Complete submission text file 0001789769-24-000034.txt   257888

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20240321.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20240321_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20240321_pre.xml EX-101.PRE 13038
18 EXTRACTED XBRL INSTANCE DOCUMENT til-20240321_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 24772163
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)